Early-pregnancy transcriptome signatures of preeclampsia: from peripheral blood to placenta

Aishwarya P Yadama1, Enrico Maiorino1, Vincent J Carey1

  • 1Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Scientific Reports
|October 13, 2020
PubMed

Insights

Maternal asthma, excess BMI, and low vitamin D increase preeclampsia risk. Shared gene signatures in blood and placenta link these conditions, offering potential for early preeclampsia prediction.

Area of Science:

  • Reproductive biology
  • Immunology
  • Genetics

Background:

  • Preeclampsia (PE) risk is associated with maternal asthma, high body mass index (BMI), and vitamin D insufficiency.
  • Previous research suggests potential links between these conditions.

Purpose of the Study:

  • To investigate shared peripheral blood and placental gene expression signatures connecting PE, maternal asthma, vitamin D insufficiency, and excess BMI.
  • To identify potential pre-clinical biomarkers for PE prediction.

Main Methods:

  • Analysis of peripheral blood gene expression from the Vitamin D Antenatal Asthma Reduction Trial (VDAART) cohort.
  • Validation of gene signatures in peripheral blood and placental tissues from independent cohorts.
  • Construction of a PE module using protein-protein interaction networks.

Main Results:

  • A core set of differentially expressed genes was identified across all four conditions (PE, asthma, low vitamin D, high BMI) in peripheral blood.
  • These shared gene signatures were confirmed in placental tissue.
  • CXC chemokine genes exhibited high connectivity and centrality in both peripheral blood and placental networks.

Conclusions:

  • Shared gene signatures highlight biological pathways involved in preeclampsia during the pre-clinical stage.
  • These findings suggest potential for early PE prediction using identified biomarkers.

Related Concept Videos